Edition:
United Kingdom

People: Editas Medicine Inc (EDIT.OQ)

EDIT.OQ on NASDAQ Stock Exchange Global Select Market

26.32USD
22 Apr 2019
Change (% chg)

-- (--)
Prev Close
$26.32
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
323,791
52-wk High
$41.40
52-wk Low
$17.90

Cox, Gerald 

Mr. Gerald Cox, M.D., Ph.D., is a Chief Medical Officer of the EDITAS MEDICINE, INC. since October 2016. Prior to joining Editas, Dr. Cox served in a variety of roles at Sanofi Genzyme, a biotechnology company, from August 2000 to August 2016, serving most recently as the Vice President of Clinical Development for Rare Diseases. Since July 1994, Dr. Cox has served as a Staff Physician in Genetics at Boston Children’s Hospital and, since August 1994, as an Instructor in Pediatrics at Harvard Medical School. Dr. Cox received his B.A. in biology from Harvard College and his M.D. and Ph.D. from the University of California at San Diego.

Basic Compensation

Total Annual Compensation, USD 100,000
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 2,367,450
Fiscal Year Total, USD 2,467,450

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

James Mullen

--

Katrine Bosley

6,091,500

Cynthia Collins

--

Charles Albright

1,266,640

Gerald Cox

2,467,450

Andrew Hirsch

246,416
As Of  31 Dec 2017